http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GT-200900090-A

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-565
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-00
filingDate 2009-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_106a6e82caea690a6720c5e0ec6198b4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a6f150c524315cc23b24356126a2462a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e90b4b7cda495ec75c9a97731bef3c72
publicationDate 2011-11-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber GT-200900090-A
titleOfInvention USE OF ESTRADIOL VALERATE OR 17B-ESTRADIOL IN COMBINATION WITH DIENOGEST IN AN ORAL THERAPY TO MAINTAIN AND / OR INCREASE THE FEMALE FREE
abstract THE INVENTION IS RELATED TO THE USE OF ESTRADIOL VALERATE OR 17B-ESTRADIOL (ESTRADIOL) IN COMBINATION WITH 17A-CYANOMETIL -17-B-HYDROXIESTRA-4, 9-DIEN-3-ONA (DIENOGEST) IN A COMBINED PRODUCT OF MULTIPLE FAS OR ONLY ONE PHASE IN AN ORAL THERAPY TO MAINTAIN AND / OR INCREASE THE FEMALE LIBID, WHEN IT WAS APPROPRIATE ALSO WITH AN ORAL CONTRACEPTION.
priorityDate 2006-10-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5757
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13791
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419554556
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419541440
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID68861
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419535674

Total number of triples: 22.